Paper20022081
Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.
Stavrou E and 1 other. Thromb Res, 2010. Cited by 133 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. Papers, record 20022081. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20022081
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Factor XII | Major topic |
| Hemostasis | Major topic |
| Thrombosis | Major topic |
| Animals | |
| Blood Coagulation | |
| Factor XII Deficiency | |
| Mice |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 HL052779 | NHLBI NIH HHS | United States | R01HL052779 | PubMed and NIH |
Source NIH RePORTER
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,604,055 | Amino acid sequence of human beta-factor XIIa. | J Biol Chem | 1983 | https://conductscience.org/library/papers/6604055 | PubMed |
| 2 | 8,665,943 | Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces. | Eur J Biochem | 1996 | https://conductscience.org/library/papers/8665943 | PubMed |
| 3 | 9,684,789 | Factor XII does not initiate prekallikrein activation on endothelial cells. | Thromb Haemost | 1998 | https://conductscience.org/library/papers/9684789 | PubMed |
| 4 | 8,447,816 | Histidine residues are essential for the surface binding and autoactivation of human coagulation factor XII. | Biochem Biophys Res Commun | 1993 | https://conductscience.org/library/papers/8447816 | PubMed |
| 5 | 17,186,468 | Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. | Am J Hum Genet | 2006 | https://conductscience.org/library/papers/17186468 | PubMed |
| 6 | 11,986,212 | Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. | Blood | 2002 | https://conductscience.org/library/papers/11986212 | PubMed |
| 7 | 10,490,591 | Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. | Mol Cell Biol | 1999 | https://conductscience.org/library/papers/10490591 | PubMed |
| 8 | 1,852,005 | Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1852005 | PubMed |
| 9 | 2,440,859 | A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation. | J Biol Chem | 1987 | https://conductscience.org/library/papers/2440859 | PubMed |
| 10 | 6,218,503 | Partial primary structure of bovine plasma fibronectin: three types of internal homology. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6218503 | PubMed |
| 11 | 9,266,689 | Partial identification of the Zn2+-binding sites in factor XII and its activation derivatives. | Eur J Biochem | 1997 | https://conductscience.org/library/papers/9266689 | PubMed |
| 12 | 9,520,414 | Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9520414 | PubMed |
| 13 | 7,252,410 | Activation of the classical pathway of complement by Hageman factor fragment. | J Exp Med | 1981 | https://conductscience.org/library/papers/7252410 | PubMed |
| 14 | 11,956,243 | Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. | J Clin Invest | 2002 | https://conductscience.org/library/papers/11956243 | PubMed |
| 15 | 2,472,397 | Mapping of a putative surface-binding site of human coagulation factor XII. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2472397 | PubMed |
| 16 | 19,372,258 | Dual role of collagen in factor XII-dependent thrombus formation. | Blood | 2009 | https://conductscience.org/library/papers/19372258 | PubMed |
| 17 | 9,834,224 | The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces. | Blood | 1998 | https://conductscience.org/library/papers/9834224 | PubMed |
| 18 | 17,405,864 | Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17405864 | PubMed |
| 19 | 5,477,337 | Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. | J Lab Clin Med | 1970 | https://conductscience.org/library/papers/5477337 | PubMed |
| 20 | 19,786,295 | Combined cis-regulator elements as important mechanism affecting FXII plasma levels. | Thromb Res | 2010 | https://conductscience.org/library/papers/19786295 | PubMed |
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 133 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,712,886 | Trypsin is as procoagulant as factor XIIa. | Bleeding Thromb Vasc Biol | 2026 | https://conductscience.org/library/papers/42712886 | PubMed |
| 42,431,204 | Quantitative Proteomic Profiling of Plasma Alterations Associated with Thrombotic Risk and Insulin Resistance in Type 1 Diabetes. | Thromb Haemost | 2026 | https://conductscience.org/library/papers/42431204 | PubMed |
| 42,298,010 | Molecular determinants of thromboinflammatory activation in inflammatory bowel disease. | J Mol Med (Berl) | 2026 | https://conductscience.org/library/papers/42298010 | PubMed |
| 41,977,339 | Severe Factor XII Deficiency in a Patient with Spontaneous Coronary Artery Dissection. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977339 | PubMed |
| 41,968,739 | Developing Safer Anticoagulant Candidates: Structure-Activity Relationship Studies of 5-Amino-Triazole-Based FXIIa Inhibitors. | Med Chem | 2026 | https://conductscience.org/library/papers/41968739 | PubMed |
| 41,481,963 | Thrombogenic characterization of alloyed and surface-modified magnesium bioresorbable metals for cardiovascular device applications. | Biomaterials | 2026 | https://conductscience.org/library/papers/41481963 | PubMed |
| 41,210,598 | A biofluid-repellent nanograss coating enhances flow of protein solutions and preserves transparency of glass capillaries upon exposure to blood. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/41210598 | PubMed |
| 40,890,099 | Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysis. | Nat Commun | 2025 | https://conductscience.org/library/papers/40890099 | PubMed |
| 40,544,393 | Proteomics of arterial thrombi in acute limb ischemia. | J Thromb Thrombolysis | 2025 | https://conductscience.org/library/papers/40544393 | PubMed |
| 40,461,568 | Contact activation of coagulation in newly inserted indwelling catheters. | Sci Rep | 2025 | https://conductscience.org/library/papers/40461568 | PubMed |
| 40,432,755 | Quantifying Thrombogenicity: A Bioanalytical Protocol for the Absorbance-Based Assessment of Vascular Implants with Plasma. | Bio Protoc | 2025 | https://conductscience.org/library/papers/40432755 | PubMed |
| 39,841,196 | Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency. | Ann Hematol | 2025 | https://conductscience.org/library/papers/39841196 | PubMed |
| 39,530,020 | A biomimetic approach towards a universal slippery liquid infused surface coating. | Beilstein J Nanotechnol | 2024 | https://conductscience.org/library/papers/39530020 | PubMed |
| 39,408,963 | Cardiovascular Disease May Be Triggered by Gut Microbiota, Microbial Metabolites, Gut Wall Reactions, and Inflammation. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39408963 | PubMed |
| 39,266,545 | A single-domain antibody targeting factor XII inhibits both thrombosis and inflammation. | Nat Commun | 2024 | https://conductscience.org/library/papers/39266545 | PubMed |
| 39,262,322 | Catheter-related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs. | Eur J Clin Invest | 2025 | https://conductscience.org/library/papers/39262322 | PubMed |
| 38,812,508 | Mast cell degranulation and bradykinin-induced angioedema - searching for the missing link. | Front Immunol | 2024 | https://conductscience.org/library/papers/38812508 | PubMed |
| 38,753,086 | Is There an Alternative Oral Anticoagulation to Vitamin-K-Antagonists for Patients with Mechanical Aortic Valve Replacement? - A Literature Review. | Cardiol Ther | 2024 | https://conductscience.org/library/papers/38753086 | PubMed |
| 38,610,717 | Cutting-Edge Techniques and Drugs for the Treatment of Pulmonary Embolism: Current Knowledge and Future Perspectives. | J Clin Med | 2024 | https://conductscience.org/library/papers/38610717 | PubMed |
| 38,254,639 | The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome. | Biomolecules | 2023 | https://conductscience.org/library/papers/38254639 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20022081
GET https://conductscience.org/api/papers/v1/20022081/references?page=2